ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Business

Orix moves to buy veterinary drugmaker, with eye on TPP

TOKYO -- Orix will purchase all outstanding shares in veterinary medicine maker Fujita Pharmaceutical this month as the company quickly prepares for what it sees as a possible big expansion of the business domestically if Japan ratifies the Trans-Pacific Partnership.

Livestock operations in Japan are expected to increase in scale if the wide-ranging trade and economic pact takes effect, raising the risk of infectious diseases among animals.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more